Rallybio to Present at Upcoming Investor Conferences

NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced its participation in the following upcoming investor conferences:

• 2024 Wells Fargo Healthcare Conference in Everett, MA on Thursday, September 5, 2024. Stephen Uden, M.D., Chief Executive Officer, will participate in a fireside chat at 3:45 p.m. ET.
• H.C. Wainwright 26^th Annual Global Investment Conference in New York, NY on Tuesday, September 10, 2024. Dr. Uden will present a corporate overview at 11:00 a.m. ET.

Live webcasts of the Wells Fargo fireside chat and H.C. Wainwright presentation will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. A replay of the webcasts will be available for 30 days following each presentation.

About Rallybio
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, an inhibitor of complement component 5 (C5), with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development. Rallybio is headquartered in New Haven, Connecticut. For more information, please visit www.rallybio.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240826376744/en/

Investors

Samantha Tracy

Rallybio Corporation

(475) 47-RALLY (Ext. 282)

investors@rallybio.com

Kevin Lui

Precision AQ

(212) 698-8691

Kevin.Lui@precisionaq.com

Media

Victoria Reynolds

Mission North

(760) 579-2134

rallybio@missionnorth.com

Source: Rallybio Corporation

FAQ

When and where is Rallybio (RLYB) presenting at the Wells Fargo Healthcare Conference in 2024?

Rallybio (RLYB) is presenting at the Wells Fargo Healthcare Conference on Thursday, September 5, 2024, in Everett, MA. CEO Stephen Uden will participate in a fireside chat at 3:45 p.m. ET.

What is the date and time of Rallybio's (RLYB) presentation at the H.C. Wainwright Global Investment Conference?

Rallybio (RLYB) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on Tuesday, September 10, 2024, in New York, NY. CEO Stephen Uden will give a corporate overview at 11:00 a.m. ET.

How can investors access Rallybio's (RLYB) presentations at the upcoming conferences?

Investors can access live webcasts of Rallybio's (RLYB) presentations through the Events and Presentations section of the company's website at www.rallybio.com. Replays will be available for 30 days following each presentation.

What type of company is Rallybio (RLYB) and what is its focus?

Rallybio (RLYB) is a clinical-stage biotechnology company that focuses on translating scientific advances into transformative therapies for patients with devastating rare diseases.